Exam Questions Flashcards
What is tolerance?
- many layers of protection imposed by immune system to prevent reaction of its cells/ antibodies against host components
What are the 3 mechanisms of tolerance?
- Evasion- how location/ sequestration has a role in protecting some sites/ tissue-specific antigens found there from exposure to immune system (passive process)
- Elimination- mechanisms that remove self-reactive lymphocytes before they can do damage (negative selection)
- Engagement- cultivating certain self-reactive cells for protection of self structures (regulatory phenotype)
How do regulatory CD4+ T cells (tTregs/ pTregs) inhibit immune responses?
> FoxP3/ CTLA-4/ IL-2R α chain (CD25)
- Contact-Dependent Mechanisms- interaction of CTLA-4 (Tregs) and CD80/86 (APCs) inhibits APC function
> decreased expression of CD80/86
> activation of IDO > creating an immunoinhibitory microenvironment - Contact-Independent Mechanisms
> secretion of immune-inhibitory cytokines (IL-10/ TGF-β/ IL-35) into surrounding area > shuts down nearby T cells/ APCs
> due to high CD25 (IL-2Rα) expression, Tregs absorb IL-2 > prevents expansion of effector T cells
What is linked suppression? > mediated by Tregs
- Tregs can inhibit both effector T cells that share the same antigen specificity/ T cells that recognize other antigens
> occurs when both Treg/ T-cell recognizing another antigen interact with same APC - when a single APC simultaneously interacts with T cells of different specificity > inhibitory signals meant for one can be transmitted to both > leads to spreading of immune suppression to include other antigens
What happens in Hashimoto’s thyroiditis?
- autoantibodies/ TH1 cells specific for thyroid antigens are produced
- DTH response > thyroid gland infiltration by lymphocytes/ macrophage/ plasma cells
- inflammatory response caused by antibodies against thyroid proteins
What happens in type 1 diabetes (IDDM)?
- autoimmune attack against insulin-producing beta cells in pancreas
- starts with CTL infiltration/ macrophage activation (insulitis) > cell-mediated DTH response > autoantibodies/ cytokine release
- beta-cell destruction mediated by auto-antibodies (ADCC/ antibody-mediated complement lysis)/ cytokines/ lytic enzymes released from activated macrophages
What happens in myasthenia gravis?
- autoimmune disease mediated by blocking antibodies
- auto-antibodies bind to AChR on muscles > block ACh binding > induce complement-mediated lysis of cells
- type II hypersensitivity
What happens in lupus?
- auto-antibodies to cells/ cellular components (DNA/ histones/ clotting factors/ RBCs/ leukocytes)
- immune complexes of auto-antibodies/ antigens deposit along blood vessel walls > type III hypersensitivity
- complement system activation > MAC/ C3a/ C5a
What happens in multiple sclerosis?
- production of autoreactive CD4+ T cells
- TH17 cells > IL-17 is hallmark
What happens in rheumatoid arthritis?
- production of antibodies that react with citrullinated protein antigens
- production of auto-antibodies (RFs) > specific for Fc region of IgG
- immune complexes formed by RFs binding to normal circulating IgG are deposited into joints
- activates complement system > type III hypersensitivity
What are 2 systemic autoimmune conditions caused by disruptions in immune regulation?
- APS-1- mutations in AIRE gene > critical for central tolerance in thymus (ensures tissue-specific antigens expressed during T cell development) > both elimination/ engagement
- IPEX- mutations in FoxP3 gene > master TF associated with regulatory T cells (both tTregs/ pTregs > central/ peripheral tolerance)
What are the 3 categories of current therapies to treat autoimmune disease?
- broad-spectrum immunosuppressive treatments > anti-inflammatory
- immunosuppression directed at specific cells/ pathways
- targeted immunotherapy > guide hots cells to new pathway
What are the 5 main mechanisms of action of treatments for autoimmune disease?
- T/ B cell-depleting agents
- targeting cell trafficking/ adhesion > fingolimod
- targeting TCR signaling
- targeting costimulatory/ accessory molecules > CTLA-4
- targeting cytokines/ cytokine signaling
How are mucosal/ barrier responses typically controlled?
- TH2 response:
> activation of ILC-2s
> TH2 specific cytokines > IL-4/ IL-5/ IL-13
> IgE > recognizes cell surface epitopes of pathogen
> dimeric IgA at mucosal surfaces
What are the immune mediators for extracellular infections?
- PRRs on phagocytic cells
- complement system activation
- antimicrobial compounds
- IgG/ IgM/ mIgA antibodies
- TFH/ TH17/ TH2 cells